EVO

#6991
Evotec SE American Depositary Shares
3.4000
+0.89%
セクター:
ベース:
利益通貨:
日中レンジ
3.4000
3.4000
1年のレンジ
2.8600
4.2700
1日の変化
+0.89%
月次変化
-9.33%
6か月変化
-20.37%
1年の変化
-20.37%
以前の終値
3.3700
Open
3.4000
Bid
Ask
Low
3.4000
High
3.4000
ボリューム
7
Open full chart

Financials

Overview 明細書 Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24 TTM

Evotec SE - American Depositary Shares each representing 1/2 of

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development. The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more. On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology.

ニュース